Rewriting the Rules: How Digital Tools Are Disrupting Drug Development

Monday, November 10, 2025

3:30 PM - 4:30 PM CT

Location:360 Stage #4, Exhibit Hall

Sponsored By

Manufacturing and Analytical Characterization

Partner Presentation-Manufacturing & Bioprocessing

Partner Presentation Speaker(s)

Anil Kane, PhD

Sr. Director, Global Technical Scientific Affairs
Thermo Fisher Scientific
Morrisville, North Carolina
Sanjay Konagurthu, Ph.D.

Sr. Director, Science and Innovation
Thermo Fisher Scientific
Morrisville, North Carolina

Description: The pharmaceutical industry no longer has the luxury of “business as usual.” Speed, precision, and efficiency are not optional — they’re survival. This talk will showcase how digital disruption is rewriting the rules of drug development and manufacturing. We’ll explore Quadrant 2® predictive modeling — a game-changer for excipient and technology selection in solubility enhancement. We’ll reveal how our dSME (digital Subject Matter Expert) merges machine connectivity, AI, and human expertise to create a manufacturing floor that learns and adapts in real time. You’ll also see how AI-powered visual inspection is slashing rejects and boosting efficiency, and how advanced PAT tools are unlocking new levels of data-driven control. This isn’t about incremental improvement. It’s about challenging old paradigms and embracing a digital future where development timelines shrink, quality rises, and pharma keeps pace with the world’s needs.

Learning Objectives:

You’ll also see how AI-powered visual inspection is slashing rejects and boosting efficiency.
Learn how advanced PAT tools are unlocking levels of data-driven control.
Challenge old paradigms and understand how embracing a digital future impacts efficiency and quality in the pharma industry.